|
Delayed
Bombay S.E.
05:01:38 18/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 90.05 INR | -0.50% |
|
-6.41% | +120.36% |
| Market Cap | 49.59B 531M 482M 445M 402M 758M 787M 5.36B 2.12B 26.76B 1.99B 1.95B 84.55B | P/E 2025 |
21.8x | P/E 2026 | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 51.13B 547M 497M 459M 414M 782M 811M 5.53B 2.19B 27.59B 2.05B 2.01B 87.17B | EV / Sales 2025 |
1.45x | EV / Sales 2026 | 1.11x |
| Free-Float |
57.95% | Yield 2025 |
0.42% | Yield 2026 | 0.59% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| MOREPENLAB | Delayed | |
| MOREPENLAB | Delayed |
| 1 week | -6.41% | ||
| Current month | -20.40% | ||
| 1 month | -25.73% | ||
| 3 months | +2.42% | ||
| 6 months | +118.97% | ||
| Current year | +120.36% |
| 1 week | 88.15 | 102 | |
| 1 month | 88.1 | 132.7 | |
| Current year | 33.44 | 150.8 | |
| 1 year | 33.44 | 150.8 | |
| 3 years | 33.44 | 150.8 | |
| 5 years | 23.65 | 150.8 | |
| 10 years | 7.21 | 150.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 30/06/2026 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 31/01/1992 |
| Director of Finance/CFO | 59 | 02/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 31/01/1992 |
Sanjay Suri
BRD | Director/Board Member | 58 | 12/08/2019 |
| Director/Board Member | 58 | 12/08/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.50% | -6.41% | +97.86% | +128.25% | 553M | ||
| -1.13% | -1.17% | +38.55% | +139.23% | 1,275B | ||
| -1.36% | -0.74% | +39.64% | +86.06% | 680B | ||
| -0.59% | -0.36% | +25.14% | +111.73% | 521B | ||
| -0.76% | +1.10% | +41.43% | +70.96% | 389B | ||
| -0.75% | -3.16% | +54.39% | +40.90% | 356B | ||
| -1.83% | -0.89% | +26.00% | +58.48% | 305B | ||
| -1.65% | -0.59% | +1.55% | +34.52% | 287B | ||
| -0.95% | -1.57% | +34.01% | +72.55% | 250B | ||
| +1.60% | -0.36% | +37.21% | +125.66% | 208B | ||
| Average | -0.74% | -0.76% | +39.58% | +86.83% | 427B | |
| Weighted average by Cap. | -0.98% | -0.55% | +34.97% | +95.63% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.12B 194M 176M 163M 147M 277M 288M 1.96B 775M 9.78B 727M 712M 30.89B | 18.06B 193M 175M 162M 146M 276M 287M 1.95B 772M 9.74B 725M 710M 30.79B |
| Net income | 1.18B 12.63M 11.47M 10.59M 9.56M 18.04M 18.73M 128M 50.49M 637M 47.39M 46.4M 2.01B | 949M 10.15M 9.22M 8.52M 7.68M 14.5M 15.06M 103M 40.59M 512M 38.1M 37.3M 1.62B |
| Net Debt | -928K -9.93K -9.02K -8.33K -7.51K -14.19K -14.73K -100K -39.7K -501K -37.27K -36.48K -1.58M | 1.54B 16.46M 14.94M 13.8M 12.45M 23.51M 24.41M 166M 65.79M 830M 61.76M 60.46M 2.62B |
Employees
1,919
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | ₹90.05 | -0.50% | 134,200 |
| 17/11/26 | ₹90.50 | -4.54% | 370,626 |
| 16/11/26 | ₹94.80 | -4.96% | 344,087 |
| 13/11/26 | ₹99.75 | +5.00% | 609,884 |
| 12/11/26 | ₹95.00 | -1.76% | 252,559 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
















